Delivery Order SPE2DB22D1106-SPE2DB25FEBP6
- Not listed
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,777.20, is for the delivery of ZYNRELEF 400-12 MG/14 ML VIAL 14ML, a pharmaceutical product. The contract has a completion date of February 3, 2025 and is a firm fixed-price delivery order. The contract is not designated as a set-aside. AmerisourceBergen holds a significant...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of ZYNRELEF 200-6 MG/7 ML VIAL 7ML pharmaceutical product, with a ceiling value of $1,744.77. The contract is a firm fixed-price delivery order with a completion date of July 14, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $10,960.70 to AmerisourceBergen Drug Corp for the supply of Zynrelef 400-12 mg/14 mL vials. This contract utilizes firm fixed pricing and was competitively awarded without a set-aside designation. The ultimate completion date is September 24, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Zynrelef is a liposomal bupivacaine and meloxicam combination product used...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Zilretta 32 mg vials. The contract has a ceiling value of $1,857.45 and is a firm fixed price contract running through April 17, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a primary vehicle...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,485.96, is for the supply of ZILRETTA 32 MG VIALS, a medical product. The contract has a performance period through March 26, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ZYMFENTRA 120 MG/ML PEN (2PK)S, a pharmaceutical product. The contract has a firm fixed price of $3,007.12 and a period of performance through June 4, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant Indefinite...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Firm Fixed Price Delivery Order with a ceiling value of $34,464.62. The contract, awarded by the Defense Logistics Agency, a defense agency, is for the delivery of ZYNLONTA 10 MG VIALS, a pharmaceutical product. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the Defense Logistics...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ZYMFENTRA 120 MG/ML PEN KITS, with a firm fixed price ceiling value of $1,503.56 and a period of performance through June 10, 2025. The contract is not set aside and was competitively awarded. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $607,495.42 and a period of performance through March 5, 2025. It is a firm-fixed-price contract for the delivery of a variety of pharmaceutical products and medical supplies, including medications across multiple therapeutic domains such as diabetes, neurology, pain management,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,503.56, is for the procurement of ZYMFENTRA 120 MG/ML PEN KITS, a medical supply item. The contract is a firm fixed price delivery order with a completion date of February 7, 2025. This contract is not set aside for any specific business type....
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FEBP6Delivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ZYNRELEF 200-6 MG/7 ML VIAL 7ML, a medical product, with a ceiling value of $2,813.84 and a period of performance through March 6, 2025. The contract is a firm fixed-price type and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 3/5/25 |